[HTML][HTML] Ototoxicity: a challenge in diagnosis and treatment

P Ganesan, J Schmiedge, V Manchaiah… - Journal of audiology …, 2018 - ncbi.nlm.nih.gov
Ototoxicity is the pharmacological adverse reaction affecting the inner ear or auditory nerve,
characterized by cochlear or vestibular dysfunction. The panorama of drug-induced hearing …

New molecular therapies for the treatment of hearing loss

Y Ma, AK Wise, RK Shepherd… - Pharmacology & …, 2019 - Elsevier
An estimated 466 million people suffer from hearing loss worldwide. Sensorineural hearing
loss is characterized by degeneration of key structures of the sensory pathway in the …

[图书][B] An introduction to the physiology of hearing

JO Pickles - 1988 - academia.edu
5. Mechanisms of Transduction and Excitation in the Cochlea.. 1 1 2 A. Introduction.......... 1 1
2 B. The cytoskeleton of the transducer region..... 1 1 3 C. Mechanisms of transduction....... 1 …

Usher syndrome (sensorineural deafness and retinitis pigmentosa): pathogenesis, molecular diagnosis and therapeutic approaches

C Bonnet, A El-Amraoui - Current opinion in neurology, 2012 - journals.lww.com
Whereas the mechanisms underlying hearing impairment in USH patients are being
unraveled, showing in particular that USH1 proteins are involved in the shaping of the hair …

Neural crest contributions to the ear: implications for congenital hearing disorders

KE Ritter, DM Martin - Hearing research, 2019 - Elsevier
Congenital hearing disorders affect millions of children worldwide and can significantly
impact acquisition of speech and language. Efforts to identify the developmental genetic …

Genetics of nonsyndromic congenital hearing loss

OK Egilmez, MT Kalcioglu - Scientifica, 2016 - Wiley Online Library
Congenital hearing impairment affects nearly 1 in every 1000 live births and is the most
frequent birth defect in developed societies. Hereditary types of hearing loss account for …

Transduction of adeno-associated virus vectors targeting hair cells and supporting cells in the neonatal mouse cochlea

X Gu, R Chai, L Guo, B Dong, W Li, Y Shu… - Frontiers in cellular …, 2019 - frontiersin.org
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary
deafness, and different viral serotypes, promoters and transduction pathways can influence …

AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss

RK Thorpe, WD Walls, R Corrigan, A Schaefer, K Wang… - Human genetics, 2022 - Springer
Autosomal dominant non-syndromic hearing loss (ADNSHL) displays gene-specific
progression of hearing loss, which is amenable to sequential audioprofiling. We sought to …

Outlook and future of inner ear therapy

J Devare, S Gubbels, Y Raphael - Hearing research, 2018 - Elsevier
Drug delivery to the inner ear is an ideal method to treat a wide variety of otologic conditions.
A broad range of potential applications is just beginning to be explored. New approaches …

Nanomedicine strategies for drug delivery to the ear

CO Pritz, J Dudas, H Rask-Andersen… - …, 2013 - Taylor & Francis
The highly compartmentalized anatomy of the ear aggravates drug delivery, which is used to
combat hearing-related diseases. Novel nanosized drug vehicles are thought to overcome …